دورية أكاديمية

Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors.

التفاصيل البيبلوغرافية
العنوان: Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors.
المؤلفون: Iritani BM; Department of Immunology, Howard Hughes Medical Institute, University of Washington, Seattle 98195, USA. biritani@u.washington.edu, Alberola-Ila J, Forbush KA, Perimutter RM
المصدر: Immunity [Immunity] 1999 Jun; Vol. 10 (6), pp. 713-22.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Print ISSN: 1074-7613 (Print) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
أسماء مطبوعة: Publication: Cambridge, MA : Cell Press
Original Publication: Cambridge, Mass. : Cell Press, c1994-
مواضيع طبية MeSH: Alleles*, Lymphocyte Subsets/*immunology , Signal Transduction/*immunology , Stem Cells/*immunology, Alkyl and Aryl Transferases/biosynthesis ; Alkyl and Aryl Transferases/genetics ; Cell Differentiation/immunology ; DNA-Binding Proteins ; Enzyme Activation/immunology ; Gene Rearrangement, B-Lymphocyte, Heavy Chain/immunology ; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/immunology ; Lymphocyte Subsets/metabolism ; Mitogen-Activated Protein Kinase Kinases ; Protein Kinases/metabolism ; Proto-Oncogene Proteins c-raf/biosynthesis ; Proto-Oncogene Proteins c-raf/genetics ; Recombinant Fusion Proteins/biosynthesis ; Recombinant Fusion Proteins/genetics ; Signal Transduction/genetics ; Stem Cells/metabolism ; Transgenes/immunology
مستخلص: Successful in-frame rearrangement of immunoglobulin heavy chain genes or T cell antigen receptor (TCR) beta chain genes in lymphocyte progenitors results in formation of pre-BCR and pre-TCR complexes. These complexes signal progenitor cells to mature, expand in cell number, and suppress further rearrangements at the immunoglobulin heavy chain or TCRbeta chain loci, thereby ensuring allelic exclusion. We used transgenic expression of a constitutively active form of c-Raf-1 (Raf-CAAX) to demonstrate that activation of the Map kinase pathway can stimulate both maturation and expansion of B and T lymphocytes, even in the absence of pre-TCR or pre-BCR formation. However, the same Raf signal did not mediate allelic exclusion. We conclude that maturation of lymphocyte progenitors and allelic exclusion require distinct signals.
References: EMBO J. 1995 Jan 16;14(2):276-85. (PMID: 7835338)
Science. 1985 Mar 29;227(4694):1597-601. (PMID: 3975629)
Nature. 1992 May 14;357(6374):161-4. (PMID: 1579166)
J Immunol. 1996 May 1;156(9):3141-50. (PMID: 8617934)
Science. 1994 Aug 12;265(5174):966-70. (PMID: 8052857)
Nature. 1995 Nov 16;378(6554):298-302. (PMID: 7477352)
Int Immunol. 1994 Aug;6(8):1257-64. (PMID: 7526894)
J Exp Med. 1991 May 1;173(5):1213-25. (PMID: 1827140)
Immunity. 1996 Nov;5(5):429-36. (PMID: 8934570)
Biochim Biophys Acta. 1998 Jun 19;1377(3):F35-78. (PMID: 9659403)
Curr Top Microbiol Immunol. 1996;217:45-59. (PMID: 8787617)
Science. 1998 Jul 17;281(5375):413-6. (PMID: 9665884)
Immunity. 1994 Jul;1(4):261-7. (PMID: 7889413)
Mol Immunol. 1996 Feb;33(3):287-96. (PMID: 8649450)
Cell. 1996 Jul 26;86(2):243-51. (PMID: 8706129)
Int Immunol. 1994 Aug;6(8):1265-8. (PMID: 7981152)
Eur J Immunol. 1996 Oct;26(10):2350-5. (PMID: 8898944)
Cell. 1985 Aug;42(1):117-27. (PMID: 3926323)
Immunity. 1996 Feb;4(2):133-44. (PMID: 8624804)
Nature. 1995 Nov 16;378(6554):303-6. (PMID: 7477353)
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4683-7. (PMID: 8643464)
Immunity. 1998 Nov;9(5):617-26. (PMID: 9846483)
Immunity. 1997 Sep;7(3):357-68. (PMID: 9324356)
EMBO J. 1993 Apr;12(4):1671-80. (PMID: 8385609)
Immunity. 1996 Nov;5(5):417-28. (PMID: 8934569)
Science. 1994 Jun 3;264(5164):1463-7. (PMID: 7811320)
Biosci Rep. 1988 Feb;8(1):3-26. (PMID: 3134960)
Science. 1994 Feb 25;263(5150):1136-9. (PMID: 7509083)
Cell. 1992 Nov 13;71(4):577-86. (PMID: 1423615)
Genes Dev. 1998 May 1;12(9):1315-26. (PMID: 9573048)
Immunity. 1998 Jul;9(1):93-103. (PMID: 9697839)
Cell. 1992 Mar 6;68(5):855-67. (PMID: 1547487)
J Immunol. 1998 May 1;160(9):4175-81. (PMID: 9574517)
Cell. 1992 Sep 4;70(5):741-50. (PMID: 1387588)
Nature. 1989 Oct 19;341(6243):651-4. (PMID: 2477711)
Immunity. 1997 Nov;7(5):601-7. (PMID: 9390684)
Immunity. 1997 Jun;6(6):703-14. (PMID: 9208843)
J Exp Med. 1998 Sep 7;188(5):931-9. (PMID: 9730894)
EMBO J. 1997 Dec 1;16(23):7019-31. (PMID: 9384581)
J Cell Biol. 1990 Dec;111(6 Pt 1):2693-701. (PMID: 2277081)
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9797-801. (PMID: 9275205)
J Exp Med. 1999 Jan 4;189(1):123-9. (PMID: 9874569)
Immunity. 1997 Nov;7(5):609-18. (PMID: 9390685)
Nature. 1988 Aug 25;334(6184):676-82. (PMID: 3261841)
Nature. 1996 Jan 4;379(6560):81-5. (PMID: 8538746)
Genes Dev. 1993 Dec;7(12B):2520-32. (PMID: 8276236)
Oncogene. 1998 Jan 15;16(2):211-6. (PMID: 9464539)
Science. 1998 Jul 17;281(5375):416-9. (PMID: 9665885)
J Exp Med. 1995 Nov 1;182(5):1389-94. (PMID: 7595209)
Adv Immunol. 1996;63:1-41. (PMID: 8787628)
Immunity. 1995 Nov;3(5):549-60. (PMID: 7584145)
J Exp Med. 1995 Nov 1;182(5):1585-90. (PMID: 7595229)
Immunity. 1998 Oct;9(4):555-63. (PMID: 9806641)
Immunity. 1997 Apr;6(4):437-47. (PMID: 9133423)
J Exp Med. 1991 Jun 1;173(6):1421-32. (PMID: 1709675)
EMBO J. 1995 Jun 1;14(11):2499-508. (PMID: 7781602)
Genes Dev. 1993 Jul;7(7B):1309-17. (PMID: 8330736)
Cell. 1995 Oct 20;83(2):301-11. (PMID: 7585947)
Genes Dev. 1994 May 1;8(9):1043-57. (PMID: 7926786)
Annu Rev Immunol. 1997;15:433-52. (PMID: 9143695)
Immunol Rev. 1998 Oct;165:167-80. (PMID: 9850860)
Genes Dev. 1997 Mar 1;11(5):654-62. (PMID: 9119229)
Science. 1994 Sep 9;265(5178):1573-7. (PMID: 8079170)
J Biol Chem. 1994 Oct 14;269(41):25699-709. (PMID: 7929275)
Nature. 1995 Feb 16;373(6515):620-3. (PMID: 7854419)
Science. 1993 Feb 5;259(5096):822-5. (PMID: 8430336)
Cell. 1996 Apr 5;85(1):107-13. (PMID: 8620529)
Curr Top Microbiol Immunol. 1997;224:19-30. (PMID: 9308225)
Immunity. 1997 Jul;7(1):69-81. (PMID: 9252121)
Cell. 1992 Sep 4;70(5):751-63. (PMID: 1516132)
Genes Dev. 1994 May 1;8(9):1030-42. (PMID: 7926785)
EMBO J. 1992 Dec;11(13):4877-86. (PMID: 1334460)
Science. 1993 May 14;260(5110):953-9. (PMID: 8493533)
J Exp Med. 1991 Mar 1;173(3):711-20. (PMID: 1900081)
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3977-81. (PMID: 1708890)
Cell. 1998 Jul 24;94(2):229-38. (PMID: 9695951)
Immunity. 1996 Dec;5(6):575-89. (PMID: 8986717)
Nature. 1995 Oct 19;377(6550):635-8. (PMID: 7566176)
Mol Cell Biol. 1993 Sep;13(9):5771-80. (PMID: 7689151)
EMBO J. 1991 Jan;10(1):93-100. (PMID: 1703490)
Immunity. 1999 Mar;10(3):323-32. (PMID: 10204488)
معلومات مُعتمدة: K08 AI001445-06 United States AI NIAID NIH HHS; T32 RR007019 United States RR NCRR NIH HHS; 1 K08 AJ01445-01 United States PHS HHS; K08 AI001445-04 United States AI NIAID NIH HHS; T32 RR07019 United States RR NCRR NIH HHS; K08 AI001445-05 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (DNA-Binding Proteins)
0 (Recombinant Fusion Proteins)
0 (V(D)J recombination activating protein 2)
EC 2.5.- (Alkyl and Aryl Transferases)
EC 2.5.1.- (p21(ras) farnesyl-protein transferase)
EC 2.7.- (Protein Kinases)
EC 2.7.11.1 (Proto-Oncogene Proteins c-raf)
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinases)
تواريخ الأحداث: Date Created: 19990714 Date Completed: 19990720 Latest Revision: 20190915
رمز التحديث: 20240627
مُعرف محوري في PubMed: PMC5310940
DOI: 10.1016/s1074-7613(00)80070-9
PMID: 10403646
قاعدة البيانات: MEDLINE
الوصف
تدمد:1074-7613
DOI:10.1016/s1074-7613(00)80070-9